Y-mAbs Therapeutics (YMAB) Earnings
|
Expand Research on YMAB
| Next EPS Date | N/A | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -3.9% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -12.1% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/6/25  |
Q325 | N/A | -$0.22 | N/A | N/A | $21.02M | N/A | N/A | N/A | ||
| 8/8/25 |
Q225 | -$0.07 | -$0.26 | +$0.19 | $19.53M | $18.37M | N/A |  | | Details | |
| 5/13/25 |
Q125 | N/A | -$0.19 | N/A | N/A | $20.84M | N/A | N/A | N/A | ||
| 3/4/25 |
Q424 | N/A | -$0.12 | N/A | N/A | $26.99M | = | N/A | N/A | ||
| 11/8/24 | Q324 | -$0.16 | -$0.15 | -$0.01 | $18.46M | $23.56M | = | | | Details | |
| 8/12/24 | Q224 | -$0.21 | -$0.12 | -$0.09 | $22.8M | $23.02M | = | | | Details | |
| 5/7/24 | Q124 | -$0.15 | -$0.14 | -$0.01 | $19.93M | $22.84M | = | | | Details | |
| 2/29/24 | Q423 | -$0.02 | -$0.21 | +$0.19 | $23.4M | $20.96M | = | | | Details |
